Prescription sales up 5.1%, IMS reports

Share this content:
U.S. sales of ethical pharmaceuticals and insulins grew by 5.1% last year to $300 billion,  according to a report from IMS Health. β€œIn 2009, demand for pharmaceuticals proved stronger than in the prior two years, yet remained at historically low levels,” said IMS's Murray Aitken.

Next Article in Products